Literature DB >> 20189025

China's irrational medical pricing scheme.

Heng Zhang.   

Abstract

Mesh:

Year:  2010        PMID: 20189025     DOI: 10.1016/S0140-6736(10)60306-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Time trends and determinants of pharmaceutical expenditure in China (1990-2009).

Authors:  Lizheng Shi; Heidi Y Yang; Gang Cheng; Qingyue Meng
Journal:  Pharmacoeconomics       Date:  2014-03       Impact factor: 4.981

2.  The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.

Authors:  Xin Zhang; Qunhong Wu; Guoxiang Liu; Ye Li; Lijun Gao; Bin Guo; Wenqi Fu; Yanhua Hao; Yu Cui; Weidong Huang; Peter C Coyte
Journal:  BMJ Open       Date:  2014-12-22       Impact factor: 2.692

3.  Access to medicines for acute illness and antibiotic use in residents: A medicines household survey in Sichuan Province, western China.

Authors:  Pengqing Deng; Jianlong Yu; Naitong Zhou; Ming Hu
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

4.  Assessment of Medical Service Pricing in China's Healthcare System: Challenges, Constraints, and Policy Recommendations.

Authors:  Wenying Xiong; Yufan Deng; Yili Yang; Yumeng Zhang; Jay Pan
Journal:  Front Public Health       Date:  2021-11-26

5.  Performance evaluation of a health insurance in Nigeria using optimal resource use: health care providers perspectives.

Authors:  Shafiu Mohammed; Aurélia Souares; Justo Lorenzo Bermejo; Rainer Sauerborn; Hengjin Dong
Journal:  BMC Health Serv Res       Date:  2014-03-14       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.